Bank of New York Mellon’s West Pharmaceutical WST Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Shares
Change %
Capital Flow Portfolio Weight Portfolio Position
2025
Q2
$702M Sell
3,206,381
-168,940
-5% -$37M 0.13% 147
2025
Q1
$756M Sell
3,375,321
-74,490
-2% -$16.7M 0.15% 134
2024
Q4
$1.13B Buy
3,449,811
+203,198
+6% +$66.6M 0.21% 87
2024
Q3
$975M Sell
3,246,613
-27,333
-0.8% -$8.2M 0.18% 114
2024
Q2
$1.08B Sell
3,273,946
-18,267
-0.6% -$6.02M 0.2% 96
2024
Q1
$1.3B Sell
3,292,213
-39,340
-1% -$15.6M 0.25% 81
2023
Q4
$1.17B Sell
3,331,553
-57,767
-2% -$20.3M 0.24% 83
2023
Q3
$1.27B Sell
3,389,320
-51,084
-1% -$19.2M 0.28% 70
2023
Q2
$1.32B Sell
3,440,404
-131,686
-4% -$50.4M 0.28% 71
2023
Q1
$1.24B Sell
3,572,090
-29,106
-0.8% -$10.1M 0.27% 77
2022
Q4
$848M Buy
3,601,196
+1,858,709
+107% +$437M 0.19% 113
2022
Q3
$429M Buy
1,742,487
+502,186
+40% +$124M 0.1% 186
2022
Q2
$375M Buy
1,240,301
+643,336
+108% +$195M 0.09% 210
2022
Q1
$245M Buy
596,965
+38,555
+7% +$15.8M 0.05% 354
2021
Q4
$262M Sell
558,410
-15,038
-3% -$7.05M 0.05% 353
2021
Q3
$243M Sell
573,448
-154,442
-21% -$65.6M 0.05% 346
2021
Q2
$261M Buy
727,890
+99,187
+16% +$35.6M 0.05% 316
2021
Q1
$177M Buy
628,703
+7,492
+1% +$2.11M 0.04% 440
2020
Q4
$176M Buy
621,211
+6,908
+1% +$1.96M 0.04% 418
2020
Q3
$169M Buy
614,303
+5,760
+0.9% +$1.58M 0.04% 389
2020
Q2
$138M Sell
608,543
-228,292
-27% -$51.9M 0.04% 425
2020
Q1
$127M Sell
836,835
-2,738
-0.3% -$417K 0.04% 373
2019
Q4
$126M Buy
839,573
+19,755
+2% +$2.97M 0.03% 494
2019
Q3
$116M Sell
819,818
-9,365
-1% -$1.33M 0.03% 524
2019
Q2
$104M Buy
829,183
+5,471
+0.7% +$685K 0.03% 576
2019
Q1
$90.8M Buy
823,712
+6,614
+0.8% +$729K 0.03% 633
2018
Q4
$80.1M Sell
817,098
-37,205
-4% -$3.65M 0.03% 627
2018
Q3
$105M Sell
854,303
-3,703
-0.4% -$457K 0.03% 597
2018
Q2
$85.2M Sell
858,006
-3,098
-0.4% -$308K 0.02% 682
2018
Q1
$76M Sell
861,104
-2,603
-0.3% -$230K 0.02% 742
2017
Q4
$85.2M Sell
863,707
-3,797
-0.4% -$375K 0.02% 718
2017
Q3
$83.5M Buy
867,504
+14,022
+2% +$1.35M 0.02% 694
2017
Q2
$80.7M Buy
853,482
+11,166
+1% +$1.06M 0.02% 683
2017
Q1
$68.7M Buy
842,316
+28,302
+3% +$2.31M 0.02% 770
2016
Q4
$69.1M Buy
814,014
+8,653
+1% +$734K 0.02% 745
2016
Q3
$60M Buy
805,361
+10,122
+1% +$754K 0.02% 768
2016
Q2
$60.3M Sell
795,239
-49,166
-6% -$3.73M 0.02% 749
2016
Q1
$58.5M Buy
844,405
+1,163
+0.1% +$80.6K 0.02% 780
2015
Q4
$50.8M Sell
843,242
-72,077
-8% -$4.34M 0.02% 837
2015
Q3
$49.5M Buy
915,319
+77,991
+9% +$4.22M 0.02% 839
2015
Q2
$48.6M Buy
837,328
+53,713
+7% +$3.12M 0.01% 914
2015
Q1
$47.2M Buy
783,615
+14,792
+2% +$891K 0.01% 933
2014
Q4
$40.9M Sell
768,823
-49,577
-6% -$2.64M 0.01% 1006
2014
Q3
$36.6M Sell
818,400
-17,339
-2% -$776K 0.01% 1060
2014
Q2
$35.3M Buy
835,739
+58,926
+8% +$2.49M 0.01% 1109
2014
Q1
$34.2M Sell
776,813
-280,657
-27% -$12.4M 0.01% 1121
2013
Q4
$51.9M Sell
1,057,470
-15,491
-1% -$760K 0.01% 868
2013
Q3
$44.2M Sell
1,072,961
-230,107
-18% -$9.47M 0.01% 934
2013
Q2
$45.8M Buy
+1,303,068
New +$45.8M 0.01% 875